CITIC Securities research indicates that the 2026 medical insurance catalog adjustment will introduce a pre-declaration mechanism to expedite the inclusion of innovative drugs. This adjustment includes expanding the scope of eligible drugs, extending the application window for conditionally approved drugs, and establishing a coordinated pricing mechanism for competitive drugs. The policy aims to support genuine and differentiated innovation while maintaining the basic function of medical insurance. AI
影响 Policy changes in China's medical insurance catalog could accelerate the adoption of innovative drugs, potentially impacting AI-driven drug discovery and development.
排序理由 The cluster discusses significant policy changes in China's medical insurance system that impact the pharmaceutical industry. [lever_c_demoted from significant: ic=1 ai=0.4]
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →